Seshiru Nakazawa, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pneumonectomy | 19 | 2022 | 1098 | 2.210 |
Why?
|
Tracheoesophageal Fistula | 2 | 2022 | 129 | 1.430 |
Why?
|
Lung Neoplasms | 29 | 2023 | 13112 | 1.120 |
Why?
|
Empyema, Pleural | 2 | 2020 | 62 | 0.900 |
Why?
|
Thoracic Surgery, Video-Assisted | 5 | 2022 | 273 | 0.840 |
Why?
|
Ribs | 2 | 2022 | 252 | 0.800 |
Why?
|
Esophageal Atresia | 1 | 2022 | 201 | 0.680 |
Why?
|
Trachea | 3 | 2022 | 1076 | 0.660 |
Why?
|
Veins | 1 | 2022 | 770 | 0.620 |
Why?
|
Pneumothorax | 1 | 2021 | 378 | 0.620 |
Why?
|
Transcription Factor TFIIIA | 1 | 2016 | 25 | 0.580 |
Why?
|
Video-Assisted Surgery | 1 | 2016 | 51 | 0.550 |
Why?
|
Home Care Services | 1 | 2021 | 608 | 0.510 |
Why?
|
Esophagus | 1 | 2021 | 1019 | 0.510 |
Why?
|
Imaging, Three-Dimensional | 7 | 2020 | 4033 | 0.500 |
Why?
|
Thoracoscopy | 4 | 2019 | 178 | 0.480 |
Why?
|
Lung | 10 | 2022 | 9858 | 0.440 |
Why?
|
Neurodegenerative Diseases | 1 | 2021 | 1060 | 0.420 |
Why?
|
Surgery, Computer-Assisted | 1 | 2020 | 1017 | 0.420 |
Why?
|
Aortic Rupture | 1 | 2014 | 312 | 0.380 |
Why?
|
Arteriovenous Fistula | 1 | 2014 | 315 | 0.370 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 7 | 2023 | 5230 | 0.340 |
Why?
|
Stathmin | 2 | 2019 | 71 | 0.320 |
Why?
|
Carcinoma, Neuroendocrine | 3 | 2021 | 332 | 0.300 |
Why?
|
Bronchography | 5 | 2019 | 74 | 0.300 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2016 | 1411 | 0.270 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2022 | 4033 | 0.260 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2014 | 1187 | 0.240 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2016 | 2016 | 0.240 |
Why?
|
Tomography, X-Ray Computed | 9 | 2022 | 20121 | 0.240 |
Why?
|
DNA Topoisomerases | 1 | 2021 | 4 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2019 | 9239 | 0.210 |
Why?
|
Carcinosarcoma | 1 | 2022 | 108 | 0.200 |
Why?
|
Thymidylate Synthase | 1 | 2021 | 75 | 0.200 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2022 | 199 | 0.190 |
Why?
|
Thoracic Wall | 1 | 2022 | 203 | 0.190 |
Why?
|
rab GTP-Binding Proteins | 1 | 2022 | 246 | 0.180 |
Why?
|
Bronchi | 4 | 2019 | 840 | 0.180 |
Why?
|
Mutation | 5 | 2022 | 29777 | 0.180 |
Why?
|
Ontario | 1 | 2020 | 383 | 0.180 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4561 | 0.180 |
Why?
|
Autoimmune Diseases | 1 | 2012 | 2134 | 0.180 |
Why?
|
Ventilators, Mechanical | 1 | 2021 | 292 | 0.170 |
Why?
|
Cough | 1 | 2022 | 555 | 0.160 |
Why?
|
Thoracostomy | 1 | 2018 | 72 | 0.160 |
Why?
|
Laryngeal Neoplasms | 1 | 2022 | 512 | 0.160 |
Why?
|
Bronchial Fistula | 1 | 2018 | 85 | 0.160 |
Why?
|
Positron-Emission Tomography | 3 | 2018 | 6237 | 0.160 |
Why?
|
Humans | 46 | 2024 | 743811 | 0.150 |
Why?
|
Tubulin | 1 | 2021 | 695 | 0.150 |
Why?
|
Indocyanine Green | 1 | 2019 | 240 | 0.150 |
Why?
|
Arteries | 1 | 2022 | 1119 | 0.150 |
Why?
|
Ubiquitination | 2 | 2024 | 1011 | 0.140 |
Why?
|
Mediastinum | 1 | 2018 | 267 | 0.140 |
Why?
|
Thymoma | 1 | 2018 | 186 | 0.140 |
Why?
|
Genes, erbB-2 | 1 | 2017 | 162 | 0.140 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2022 | 1691 | 0.140 |
Why?
|
Thymus Neoplasms | 1 | 2018 | 268 | 0.130 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2016 | 264 | 0.130 |
Why?
|
I-kappa B Kinase | 1 | 2016 | 252 | 0.130 |
Why?
|
Pleura | 2 | 2018 | 235 | 0.130 |
Why?
|
Inclusion Bodies | 1 | 2016 | 279 | 0.130 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2017 | 154 | 0.130 |
Why?
|
Neoplasm Metastasis | 3 | 2020 | 4848 | 0.130 |
Why?
|
Quality of Life | 1 | 2016 | 12788 | 0.130 |
Why?
|
Aged | 22 | 2021 | 163178 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2018 | 266 | 0.120 |
Why?
|
Mutant Proteins | 1 | 2016 | 500 | 0.120 |
Why?
|
Mutagenesis, Insertional | 1 | 2017 | 654 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 381 | 0.120 |
Why?
|
Liver Neoplasms | 2 | 2024 | 4251 | 0.110 |
Why?
|
Paraganglioma | 1 | 2015 | 143 | 0.110 |
Why?
|
Abdominal Neoplasms | 1 | 2015 | 292 | 0.110 |
Why?
|
Pulmonary Veins | 2 | 2016 | 761 | 0.110 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 807 | 0.110 |
Why?
|
Colorectal Neoplasms | 3 | 2019 | 6773 | 0.110 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2018 | 451 | 0.110 |
Why?
|
Caspases | 1 | 2016 | 928 | 0.110 |
Why?
|
Laparoscopy | 2 | 2015 | 2148 | 0.110 |
Why?
|
Neuroendocrine Tumors | 1 | 2019 | 594 | 0.110 |
Why?
|
Pulmonary Artery | 2 | 2019 | 1911 | 0.110 |
Why?
|
Thoracic Neoplasms | 1 | 2015 | 268 | 0.110 |
Why?
|
NF-kappa B | 2 | 2024 | 2500 | 0.110 |
Why?
|
Salvage Therapy | 1 | 2019 | 1275 | 0.110 |
Why?
|
Mikulicz' Disease | 1 | 2012 | 8 | 0.110 |
Why?
|
Models, Anatomic | 1 | 2016 | 690 | 0.110 |
Why?
|
Submandibular Gland | 1 | 2012 | 86 | 0.100 |
Why?
|
Crystallography, X-Ray | 1 | 2016 | 2011 | 0.100 |
Why?
|
Amino Acid Substitution | 1 | 2016 | 1793 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2024 | 2217 | 0.100 |
Why?
|
Male | 23 | 2022 | 349776 | 0.100 |
Why?
|
Prednisolone | 1 | 2012 | 334 | 0.090 |
Why?
|
Sarcoma | 1 | 2022 | 1898 | 0.090 |
Why?
|
Membrane Transport Proteins | 1 | 2016 | 1030 | 0.090 |
Why?
|
Pancreatectomy | 1 | 2015 | 804 | 0.090 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2568 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2021 | 3510 | 0.090 |
Why?
|
Treatment Outcome | 8 | 2022 | 63042 | 0.090 |
Why?
|
Lymphatic Diseases | 1 | 2012 | 323 | 0.090 |
Why?
|
HeLa Cells | 1 | 2016 | 3130 | 0.090 |
Why?
|
Adenocarcinoma | 2 | 2019 | 6363 | 0.090 |
Why?
|
Middle Aged | 19 | 2021 | 213241 | 0.080 |
Why?
|
Female | 23 | 2022 | 380020 | 0.080 |
Why?
|
Plasma Cells | 1 | 2012 | 593 | 0.080 |
Why?
|
Aged, 80 and over | 10 | 2021 | 57744 | 0.080 |
Why?
|
HEK293 Cells | 1 | 2016 | 4204 | 0.070 |
Why?
|
Retrospective Studies | 9 | 2022 | 77410 | 0.070 |
Why?
|
Recombinant Proteins | 1 | 2016 | 6620 | 0.070 |
Why?
|
Sampling Studies | 2 | 2017 | 622 | 0.070 |
Why?
|
Cell Proliferation | 4 | 2024 | 10477 | 0.070 |
Why?
|
Models, Molecular | 1 | 2016 | 5445 | 0.070 |
Why?
|
Colonic Neoplasms | 2 | 2018 | 2542 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2022 | 8430 | 0.070 |
Why?
|
Prognosis | 7 | 2019 | 29052 | 0.060 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3463 | 0.060 |
Why?
|
Neoplastic Processes | 1 | 2024 | 35 | 0.060 |
Why?
|
Neural Cell Adhesion Molecule L1 | 1 | 2004 | 40 | 0.060 |
Why?
|
Protein Binding | 1 | 2016 | 9377 | 0.060 |
Why?
|
Apoptosis | 2 | 2017 | 9718 | 0.060 |
Why?
|
Adult | 12 | 2022 | 213889 | 0.060 |
Why?
|
Macrophages, Peritoneal | 1 | 2004 | 251 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5170 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2012 | 2107 | 0.050 |
Why?
|
Lung Diseases | 1 | 2012 | 1887 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2017 | 3142 | 0.050 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2022 | 185 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12954 | 0.050 |
Why?
|
Antigens, Differentiation | 1 | 2004 | 927 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2023 | 16674 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2022 | 15281 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2019 | 39001 | 0.040 |
Why?
|
Survival Rate | 3 | 2019 | 12786 | 0.040 |
Why?
|
Lymphatic Metastasis | 2 | 2017 | 2924 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2017 | 3617 | 0.040 |
Why?
|
Ubiquitin | 1 | 2024 | 851 | 0.040 |
Why?
|
Phagocytosis | 1 | 2004 | 1539 | 0.040 |
Why?
|
beta Catenin | 1 | 2023 | 1060 | 0.040 |
Why?
|
Signal Transduction | 2 | 2016 | 23398 | 0.040 |
Why?
|
RNA, Messenger | 3 | 2023 | 13028 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2017 | 3480 | 0.040 |
Why?
|
Receptors, Immunologic | 1 | 2004 | 1423 | 0.040 |
Why?
|
Mastectomy, Segmental | 1 | 2022 | 956 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15518 | 0.040 |
Why?
|
Coloring Agents | 1 | 2019 | 565 | 0.040 |
Why?
|
GTP Phosphohydrolases | 1 | 2019 | 508 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2023 | 1222 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3591 | 0.030 |
Why?
|
Acrylamides | 1 | 2017 | 255 | 0.030 |
Why?
|
Thoracic Cavity | 1 | 2015 | 13 | 0.030 |
Why?
|
Patient Positioning | 1 | 2017 | 324 | 0.030 |
Why?
|
Abdominal Cavity | 1 | 2015 | 52 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1861 | 0.030 |
Why?
|
Mesenteric Veins | 1 | 2013 | 89 | 0.030 |
Why?
|
Mesenteric Artery, Superior | 1 | 2013 | 101 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2004 | 2916 | 0.030 |
Why?
|
Diaphragm | 1 | 2015 | 349 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3769 | 0.030 |
Why?
|
Fluorine Radioisotopes | 1 | 2016 | 443 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2017 | 986 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11036 | 0.030 |
Why?
|
Tumor Burden | 1 | 2017 | 1917 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2019 | 4749 | 0.020 |
Why?
|
Hemoptysis | 1 | 2012 | 155 | 0.020 |
Why?
|
Monitoring, Intraoperative | 1 | 2017 | 957 | 0.020 |
Why?
|
Kidney Neoplasms | 2 | 2018 | 4260 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6895 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4183 | 0.020 |
Why?
|
Paclitaxel | 1 | 2017 | 1705 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 2016 | 1262 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2019 | 2039 | 0.020 |
Why?
|
Drainage | 1 | 2015 | 1142 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2944 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 3504 | 0.020 |
Why?
|
Reoperation | 1 | 2017 | 4200 | 0.020 |
Why?
|
Lung Injury | 1 | 2012 | 432 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6170 | 0.020 |
Why?
|
Preoperative Care | 1 | 2016 | 2251 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6750 | 0.020 |
Why?
|
Radiography | 1 | 2018 | 7010 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13691 | 0.020 |
Why?
|
Wounds, Nonpenetrating | 1 | 2012 | 795 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 2647 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6539 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11360 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5216 | 0.020 |
Why?
|
Cell Surface Extensions | 1 | 2004 | 67 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12243 | 0.010 |
Why?
|
Enzyme Precursors | 1 | 2004 | 176 | 0.010 |
Why?
|
Myosin-Light-Chain Kinase | 1 | 2004 | 100 | 0.010 |
Why?
|
Patient Selection | 1 | 2016 | 4210 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2019 | 7880 | 0.010 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2004 | 315 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14714 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12944 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5532 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2004 | 2327 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2004 | 2256 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 1284 | 0.010 |
Why?
|
Cytoskeleton | 1 | 2004 | 1185 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 72252 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 19894 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2004 | 3701 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 23327 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40038 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2004 | 2440 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2004 | 6380 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2004 | 2453 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17439 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2914 | 0.010 |
Why?
|
Phosphorylation | 1 | 2004 | 8436 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13809 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 18107 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2004 | 5021 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 56392 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2004 | 19232 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2004 | 9272 | 0.000 |
Why?
|
Adolescent | 1 | 2015 | 85729 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2004 | 21824 | 0.000 |
Why?
|
Mice | 1 | 2004 | 81154 | 0.000 |
Why?
|
Animals | 1 | 2004 | 168660 | 0.000 |
Why?
|